Shots:

• Enzyre to receive funding to advance its existing technology for the development of the diagnostic device- allowing hemophilia patients to automatically determine their coagulation status at home and transfer test results to HCPs via app
• The focus of the collaboration is to deliver patient-centric- personalized healthcare to patients and to advance SOC of patients with bleeding disorders
• Enzyre's technology is a small single-use diagnostic tool that requires a small volume of blood and is able to measure ~12 reactions simultaneously with high sensitivity and specificity- providing benefits to patients by avoiding crisis occurs by changing coagulation status- reduces GP consultation visits- thus optimizing treatment for the patients

Click here to­ read full press release/ article 

 Ref: PRNewswire | Image: Takeda- Enzyre